Note: Ingredients listed on restricted chemical lists
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
10-30
EC/CAS
1333-86-4
Name of the chemical
Carbon black
Concentration
5-10
General Information
Revision date
2013-10-15
Product name
QUIK STIK White; Blue; Black; Purple; Yellow; Red; Green; Orange
1.2.2. Uses advised against
FOR INDUSTRIAL USE ONLY
Emergency telephone
1-800-424-9300, +1-703-527-3887
Icons in SDS
Company Information
company name
LA-CO Industries, Inc
Section 2
SECTION 2: Hazards identification
(29 CFR 1910.1200) This MSDS reflects the health, physical and environmental hazards of the paint released by this product. Because of the nature of the finished product i.e. the fact that the paint is in solid form, and given that the paint is released in very small amounts during normal use, the user of the product and/or the reader of this MSDS should consider the potential exposure to the paint to be minimal and controlled during the normal use of the product. Refer to relevant sections of the MSDS (7 and 13) for additional information on handling and disposal considerations. To avoid any potential hazard and to minimize the risk of exposure, it is important that the user of the product does NOT heat, burn or expose it to a source of intense heat unless the product is specifically intended for use on hot surfaces. Emergency overview Physical state : Solid in cylindrical form. Color : Yellow./Red./Green./Orange./White./Blue./Black./Purple. Odor : Solvent.
Hazard statements
NOT EXPECTED TO PRODUCE SIGNIFICANT ADVERSE HEALTH EFFECTS WHEN THE RECOMMENDED INSTRUCTIONS FOR USE ARE FOLLOWED.
Potential Acute Health Effects
Inhalation : No known significant effects or critical hazards. Ingestion : No known significant effects or critical hazards. Skin : No known significant effects or critical hazards. Eyes : No known significant effects or critical hazards. Potential chronic health effects
Potential chronic health
No known significant effects or critical hazards. Carcinogenicity : No known significant effects or critical hazards. Mutagenicity : No known significant effects or critical hazards.
Teratogenic Effects
No known significant effects or critical hazards. Developmental effects : No known significant effects or critical hazards. Fertility effects : No known significant effects or critical hazards. Target organs : No known significant effects or critical hazards. Over-exposure signs/symptoms Inhalation : No known significant effects or critical hazards. Ingestion : No known significant effects or critical hazards. Skin : No known significant effects or critical hazards. Eyes : No known significant effects or critical hazards. Medical conditions aggravated by overexposure : None known. See toxicological information (Section 11)